FORT WORTH, Texas, March 12, 2025--(BUSINESS WIRE)--Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell," "we," "our," "us," "management," or the "Company"), a leader in ...

Omnicell, Inc. OMCL has witnessed strong momentum in the past year. Shares of the company have risen 41.6% against a 11.3% decline of the industry during the same time frame. The S&P 500 composite ...

AgCountry Farm Credit Services is proud to announce that it has awarded the Benefit Fund of McKenzie Health $15,000 as a ...

Omnicell (OMCL) announced that Nchacha Etta will be stepping down from his role as executive VP and CFO, effective September 15 or until a successor is named. Etta will continue to serve as CFO ...

The chief financial officer of Omnicell plans to step down sometime this year. The maker of automated medication-management systems said Wednesday that Nchacha Etta intends to depart on Sept.

Omnicell, Inc. OMCL reported fourth-quarter 2024 adjusted earnings per share (EPS) of 60 cents, which surged 81.8% year over year. The metric also beat the Zacks Consensus Estimate by 5.2%.

Omnicell (OMCL) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of ...

In the latest quarter, 4 analysts provided ratings for Omnicell OMCL, showcasing a mix of bullish and bearish perspectives. Summarizing their recent assessments, the table below illustrates the ...

Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in transforming the pharmacy and ...